H63D Syndrome and Oshtoran Syndrome destroy lives via NTBI iron.

If your doctor has never heard of NTBI, run. It's your life!

In the rapidly evolving landscape of hematology and internal medicine, an alarming knowledge gap persists among a shockingly large number of medical practitioners, including those who consider themselves specialists, regarding the intricacies of iron metabolism disorders, particularly H63D Syndrome. This article aims to elucidate the critical importance of understanding non-transferrin-bound iron (NTBI), transferrin saturation, and the H63D genetic variant, while emphasizing the necessity for medical professionals to stay abreast of these developments.

The NTBI Paradigm: A Biological Axiom of Utmost Concern

It is nothing short of scandalous that a fundamental biological axiom remains unrecognized or underappreciated by an alarmingly high number of physicians, even those purporting to be experts in the field: when transferrin saturation exceeds 50%, there is an exponential increase in the formation of cytotoxic non-transferrin-bound iron (NTBI). This phenomenon represents a critical threshold in iron homeostasis, beyond which cellular damage becomes inevitable due to iron's propensity for generating harmful free radicals. This is not a matter of debate or speculation – it is an irrefutable biological fact, as firmly established as the presence of DNA in cells or the necessity of oxygen for human survival. The widespread ignorance of this fact among medical professionals is a grave concern that needs immediate addressing.

H63D Syndrome: A Paradigm Shift in Iron Disorder Understanding

H63D Syndrome, with its complex pathophysiology, challenges traditional views on iron-related disorders. It is characterized by:

1. Chronically elevated transferrin saturation levels in individuals with a homozygous HFE H63D mutation, which for some time was mistakenly considered rather harmless - but it is not! 3% of all homozygous carriers develop haemochromatosis, 10% develop H63D syndrome

2. Relatively low ferritin levels

3. The formation of toxic NTBI

The syndrome manifests in three distinct types, each with its own set of clinical presentations and challenges. The medical community must recognize that the inability to detect these issues through standard imaging techniques does not negate their existence or impact.

The Imperative of Continued Medical Education and Critical Information Sources

In an era of unprecedented access to information, ignorance is no longer a defensible position for delivering suboptimal care. Medical professionals have a plethora of resources at their disposal, including: Google Scholar, ResearchGate, Zenodo, Figshare, openAIRE, Authorea Harvard Dataverse, Researchsquare and other reliable databases and publications. For years the heave been growing, offering a wide choice of academic work, some even peer-reviewed (the best a paper can get).

We boycott PubMed

It is crucial to note that the H63D Research Consortium decided in 2020 not to engage with PubMed. This deliberate boycott stems from PubMed's self-discreditation during the recent SARS-2 ("Corona") pandemic, where it functioned as a multiplier for pharmaceutical industry and political interests rather than an unbiased scientific resource. Medical professionals are strongly encouraged to seek information from more reliable and independent sources.

Times have changed

Relying solely on outdated textbooks, compromised databases, or traditional paradigms is not only anachronistic but potentially a legal liability. Medical professionals have an ethical obligation to provide care based on the most current and unbiased scientific understanding. Failure to incorporate the latest knowledge about H63D Syndrome into diagnostic and treatment protocols may be considered willful negligence. It is crucial to emphasize that to ignore a well-defined syndrome is a highway to malpractice. This stark reality underscores the gravity of remaining uninformed or dismissive of H63D Syndrome and its implications.

Patients are increasingly aware of their rights to proper care and diagnosis, potentially exposing practitioners to legal ramifications if they fail to adhere to best practices. The medical community must recognize that the era of unchallenged medical authority is over. In today's information age, patients have access to extensive resources and are more likely to question diagnoses and treatment plans that do not align with the latest scientific understanding.

Therefore, it is not just a matter of best practice, but a legal imperative for medical professionals to stay informed about conditions like H63D Syndrome. Ignorance or dismissal of such well-documented syndromes could lead to misdiagnosis, improper treatment, and ultimately, legal action against the healthcare provider. The potential for malpractice suits in such cases is not just a possibility, but a likely outcome if proper care and consideration are not given to these emerging areas of medical knowledge.

Clinical Implications and Diagnostic Challenges

The cascade of cellular damage initiated by NTBI in H63D Syndrome occurs independently of a practitioner's belief or recognition. Key points for clinicians to remember include:

1. The core pathomechanism of H63D Syndrome involves NTBI-iron formation and a constellation of low ferritin, low transferrin, and/or high transferrin saturation.

2. Standard imaging techniques (Histology, X-ray, MRI, CT scans) are not able to detect NTBI-iron, never! It is imperative to understand this fact.

3. Advanced imaging techniques such as transcranial B-mode sonography (a standard method for Parkinson's syndromes for well over a decade) and DAT scintigraphy may be necessary to visualize neurological impacts once the Substantia nigra (brain) is affected.

Ethical and Legal Considerations

Medical professionals have an ethical obligation to provide care based on the most current and unbiased scientific understanding. Failure to incorporate the latest knowledge about H63D Syndrome into diagnostic and treatment protocols may be considered willful negligence. Patients are increasingly aware of their rights to proper care and diagnosis, potentially exposing practitioners to legal ramifications if they fail to adhere to best practices.

Conclusion

The medical community must elevate its practice through continuous education, critical evaluation of information sources, and adherence to the latest scientific evidence, particularly in the realm of H63D Syndrome and iron metabolism disorders. Resources such as www.H63D.org provide comprehensive information, including links to scientific papers and reference materials. By embracing this knowledge, critically assessing information sources, and incorporating unbiased findings into clinical practice, medical professionals can ensure they are providing the highest standard of care while adhering to their ethical obligations and protecting themselves from potential legal challenges.